Viatris Inc.
VTRS
#1201
Rank
$19.354 B
Marketcap
United States
Country
$16.85
Share price
3.50%
Change (1 day)
73.03%
Change (1 year)
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also…
Key Metrics
Trailing P/E
—
Forward P/E
6.39
EPS (TTM)
$-0.37
Forward EPS
$2.66
Price / Book
1.35
EV / EBITDA
7.4x
Beta
0.88
Dividend Yield
2.80%
Return on Equity
-2.75%
Return on Assets
2.67%
Debt / Equity
95.53
Current Ratio
1.58
Gross Margin
40.31%
Operating Margin
12.55%
Net Profit Margin
-2.79%
Free Cash Flow
$2.677B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 18
+4.65%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$14.300B
Latest Net Income$-3,514,900,000
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Viatris Inc. with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
VTRS
No recent news available. Set FINNHUB_API_KEY to enable news.
